Skip Navigation

JNCI Journal of the National Cancer Institute 1999 91(12):992-994; doi:10.1093/jnci/91.12.992
© 1999 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Arnold, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arnold, K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 91, No. 12, 992-994, June 16, 1999
© 1999 Oxford University Press

NEWS

High-Dose Chemo and Breast Cancer: Early Results Spark Debate

Katherine Arnold

The formal presentation of preliminary results from five high-dose chemotherapy clinical trials for breast cancer brought an anti-climactic close to a subject that attracted a flurry of media attention earlier this year. It also opened the door for debate among the scientific community on what should be done next.

Four of the five studies presented in Atlanta at the 35th Annual Meeting of the American Society of Clinical Oncology in May showed no benefit in survival for women with breast cancer receiving high-dose therapy over those who received standard . . . [Full Text of this Article]

High Toxicity

Further Analysis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?